1. Bristol-Myers gets breakthrough status for Opdivo-Yervoy combo in liver cancer — Roche SMA trial of risdiplam hits target— AbbVie submits sNDA for Imbruvica/Rituximab combo for CLL — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Word is out.

Discussion in 'CSI Laboratories' started by anonymous, Jun 10, 2017 at 12:47 AM.

  1. anonymous

    anonymous Guest

    Hey Ron, there's a mole inside or closely related to CSI who's telling folks you're in a lot deep doo financially. Says you're trying to hide it. Hmmmmm......says others near the top know this. She usually is reliable. Oh well..............